Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mara Ardine

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
JBMR Plus|February 22, 2021
The Interaction of Lean Body Mass With Fat Body Mass Is Associated With Vertebral Fracture Prevalence in Women With Early Breast Cancer Undergoing Aromatase Inhibitor TherapySara Monteverdi, Rebecca Pedersini, Fabio Gallo, et al.
Scientific Reports|June 22, 2021
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapyRebecca Pedersini, Pierluigi di Mauro, Sara Bosio, et al.
JAMA Network Open|September 28, 2019
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor TherapyRebecca Pedersini, Vito Amoroso, Filippo Maffezzoni, et al.
International Journal of Nursing Practice|September 22, 2020
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the deviceRebecca Pedersini, Carla Fornaro, Pierluigi di Mauro, et al.
Journal of Geriatric Oncology|April 18, 2020
Efficacy of Eribulin mesylate in older patients with breast cancer: A pooled analysis of clinical trial and real-world dataRebecca Pedersini, Pierluigi di Mauro, Vito Amoroso, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1α and Relation to Clinical ResponseDaniele Generali, Alfredo Berruti, Maria Rosa Cappelletti, et al.
Breast Cancer Research and Treatment|May 4, 2006
Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patientsMarco Tampellini, Alfredo Berruti, Raffaella Bitossi, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
JBMR Plus|February 22, 2021
The Interaction of Lean Body Mass With Fat Body Mass Is Associated With Vertebral Fracture Prevalence in Women With Early Breast Cancer Undergoing Aromatase Inhibitor TherapySara Monteverdi, Rebecca Pedersini, Fabio Gallo, et al.
Scientific Reports|June 22, 2021
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapyRebecca Pedersini, Pierluigi di Mauro, Sara Bosio, et al.
JAMA Network Open|September 28, 2019
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor TherapyRebecca Pedersini, Vito Amoroso, Filippo Maffezzoni, et al.
International Journal of Nursing Practice|September 22, 2020
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the deviceRebecca Pedersini, Carla Fornaro, Pierluigi di Mauro, et al.
Journal of Geriatric Oncology|April 18, 2020
Efficacy of Eribulin mesylate in older patients with breast cancer: A pooled analysis of clinical trial and real-world dataRebecca Pedersini, Pierluigi di Mauro, Vito Amoroso, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1α and Relation to Clinical ResponseDaniele Generali, Alfredo Berruti, Maria Rosa Cappelletti, et al.
Breast Cancer Research and Treatment|May 4, 2006
Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patientsMarco Tampellini, Alfredo Berruti, Raffaella Bitossi, et al.
Pageof 2